DAVID NOLTE: Open Payments
NPI 1245860436 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,194 in 136 payments from 29 companies in 2025. Trend: 2023 $54 · 2024 $448 · 2025 $3,194
Food & beverage: $3,194
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 10 | $304 |
| UCB, Inc. | 16 | $301 |
| HARMONY BIOSCIENCES LLC | 8 | $300 |
| Biogen, Inc. | 8 | $222 |
| Lundbeck LLC | 8 | $218 |
| JAZZ PHARMACEUTICALS INC. | 10 | $212 |
| PFIZER INC. | 9 | $170 |
| Lilly USA, LLC | 10 | $148 |
| Neurocrine BioSciences, Inc. | 7 | $145 |
| EMD Serono, Inc. | 1 | $128 |
Products named: FYCOMPA, WAKIX, VYEPTI, EPIDIOLEX, NURTEC ODT, Briviact, KISUNLA, INGREZZA.
Industry payments across IN — which companies pay providers there.
